ATE395060T1 - Verwendung von tenatoprazol zur behandlung von gastroösophogalem reflux - Google Patents
Verwendung von tenatoprazol zur behandlung von gastroösophogalem refluxInfo
- Publication number
- ATE395060T1 ATE395060T1 AT03778427T AT03778427T ATE395060T1 AT E395060 T1 ATE395060 T1 AT E395060T1 AT 03778427 T AT03778427 T AT 03778427T AT 03778427 T AT03778427 T AT 03778427T AT E395060 T1 ATE395060 T1 AT E395060T1
- Authority
- AT
- Austria
- Prior art keywords
- tenatoprazole
- reflux
- gastroesophogal
- treat
- gen
- Prior art date
Links
- ZBFDAUIVDSSISP-UHFFFAOYSA-N 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine Chemical compound N=1C2=NC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C ZBFDAUIVDSSISP-UHFFFAOYSA-N 0.000 title abstract 3
- 229950008375 tenatoprazole Drugs 0.000 title abstract 3
- 238000010992 reflux Methods 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 230000000954 anitussive effect Effects 0.000 abstract 1
- 230000003257 anti-anginal effect Effects 0.000 abstract 1
- 230000001088 anti-asthma Effects 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 229940124584 antitussives Drugs 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 230000002439 hemostatic effect Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 229940126409 proton pump inhibitor Drugs 0.000 abstract 1
- 239000000612 proton pump inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0213113A FR2845915B1 (fr) | 2002-10-21 | 2002-10-21 | Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE395060T1 true ATE395060T1 (de) | 2008-05-15 |
Family
ID=32050603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03778427T ATE395060T1 (de) | 2002-10-21 | 2003-10-21 | Verwendung von tenatoprazol zur behandlung von gastroösophogalem reflux |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20070066659A1 (de) |
| EP (2) | EP1553943B1 (de) |
| JP (1) | JP2006508083A (de) |
| KR (1) | KR101186034B1 (de) |
| CN (2) | CN102920705A (de) |
| AT (1) | ATE395060T1 (de) |
| AU (1) | AU2003285426A1 (de) |
| BR (1) | BR0315458A (de) |
| CA (1) | CA2503212C (de) |
| CY (1) | CY1108248T1 (de) |
| DE (1) | DE60321025D1 (de) |
| DK (2) | DK2014290T3 (de) |
| ES (2) | ES2306905T3 (de) |
| FR (1) | FR2845915B1 (de) |
| PT (1) | PT1553943E (de) |
| SI (1) | SI1553943T1 (de) |
| WO (1) | WO2004037255A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2845917B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire |
| FR2845916B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine |
| FR2848555B1 (fr) * | 2002-12-16 | 2006-07-28 | Negma Gild | Enantiomere(-)du tenatoprazole et son application en therapeutique |
| FR2871800B1 (fr) * | 2004-06-17 | 2006-08-25 | Sidem Pharma Sa Sa | Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| JPH0643426B2 (ja) | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
| SE9603725D0 (sv) * | 1996-10-11 | 1996-10-11 | Astra Ab | New teatment |
| PT1736144E (pt) * | 1998-05-18 | 2016-02-10 | Takeda Pharmaceutical | Comprimidos de desintegração oral |
| JP2002537336A (ja) * | 1999-02-26 | 2002-11-05 | ニトロメド インコーポレーテッド | ニトロソ化およびニトロシル化されたプロトンポンプ阻害剤、組成物および使用方法 |
| SE0100823D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method I to obtain microparticles |
| SE9903831D0 (sv) * | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
| WO2003097011A1 (en) * | 2002-05-17 | 2003-11-27 | Eisai Co., Ltd. | Compositions and methods using proton pump inhibitors |
| FR2845917B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire |
| FR2845916B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine |
| FR2848555B1 (fr) * | 2002-12-16 | 2006-07-28 | Negma Gild | Enantiomere(-)du tenatoprazole et son application en therapeutique |
| FR2871800B1 (fr) * | 2004-06-17 | 2006-08-25 | Sidem Pharma Sa Sa | Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique |
-
2002
- 2002-10-21 FR FR0213113A patent/FR2845915B1/fr not_active Expired - Fee Related
-
2003
- 2003-10-21 CA CA2503212A patent/CA2503212C/fr not_active Expired - Fee Related
- 2003-10-21 ES ES03778427T patent/ES2306905T3/es not_active Expired - Lifetime
- 2003-10-21 AU AU2003285426A patent/AU2003285426A1/en not_active Abandoned
- 2003-10-21 WO PCT/FR2003/003122 patent/WO2004037255A1/fr active IP Right Grant
- 2003-10-21 EP EP03778427A patent/EP1553943B1/de not_active Expired - Lifetime
- 2003-10-21 DK DK08000893.1T patent/DK2014290T3/da active
- 2003-10-21 ES ES08000893T patent/ES2412395T3/es not_active Expired - Lifetime
- 2003-10-21 AT AT03778427T patent/ATE395060T1/de active
- 2003-10-21 DE DE60321025T patent/DE60321025D1/de not_active Expired - Lifetime
- 2003-10-21 PT PT03778427T patent/PT1553943E/pt unknown
- 2003-10-21 BR BR0315458-0A patent/BR0315458A/pt not_active Application Discontinuation
- 2003-10-21 CN CN2012102653624A patent/CN102920705A/zh active Pending
- 2003-10-21 KR KR1020057006851A patent/KR101186034B1/ko not_active IP Right Cessation
- 2003-10-21 EP EP08000893A patent/EP2014290B1/de not_active Expired - Lifetime
- 2003-10-21 SI SI200331298T patent/SI1553943T1/sl unknown
- 2003-10-21 CN CNA2003801071998A patent/CN1753674A/zh active Pending
- 2003-10-21 JP JP2004546114A patent/JP2006508083A/ja active Pending
- 2003-10-21 DK DK03778427T patent/DK1553943T3/da active
- 2003-10-21 US US10/531,900 patent/US20070066659A1/en not_active Abandoned
-
2008
- 2008-08-11 CY CY20081100837T patent/CY1108248T1/el unknown
-
2011
- 2011-02-25 US US13/035,547 patent/US20110152314A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1553943A1 (de) | 2005-07-20 |
| ES2306905T3 (es) | 2008-11-16 |
| CN1753674A (zh) | 2006-03-29 |
| ES2412395T3 (es) | 2013-07-11 |
| FR2845915A1 (fr) | 2004-04-23 |
| EP2014290A2 (de) | 2009-01-14 |
| KR101186034B1 (ko) | 2012-09-25 |
| WO2004037255A1 (fr) | 2004-05-06 |
| DK2014290T3 (da) | 2013-05-06 |
| US20110152314A1 (en) | 2011-06-23 |
| AU2003285426A1 (en) | 2004-05-13 |
| PT1553943E (pt) | 2008-08-20 |
| US20070066659A1 (en) | 2007-03-22 |
| CA2503212C (fr) | 2012-03-13 |
| JP2006508083A (ja) | 2006-03-09 |
| KR20050090374A (ko) | 2005-09-13 |
| AU2003285426A8 (en) | 2004-05-13 |
| EP2014290A3 (de) | 2009-03-04 |
| DK1553943T3 (da) | 2008-09-15 |
| CY1108248T1 (el) | 2014-02-12 |
| CA2503212A1 (fr) | 2004-05-06 |
| EP1553943B1 (de) | 2008-05-14 |
| EP2014290B1 (de) | 2013-01-23 |
| SI1553943T1 (sl) | 2008-12-31 |
| CN102920705A (zh) | 2013-02-13 |
| FR2845915B1 (fr) | 2006-06-23 |
| BR0315458A (pt) | 2005-08-23 |
| DE60321025D1 (de) | 2008-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001039759A3 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| DE69507029D1 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
| MX9709977A (es) | Compuestos de (acido sulfinico, acido sulfonico, sulfonilamino o sulfinilamino) n-[(aminoiminometil) fenilalquil] azaheterociclilamida sustituidos. | |
| IS4576A (is) | Lyfjasamsetning sem inniheldur prótónudælulata | |
| NO20014046L (no) | Gabapentinderivater for forhindring og behandling av visceral smerte | |
| ATE388951T1 (de) | Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes | |
| TR199700917T1 (xx) | Oral farmas�tik dozaj formlar�. | |
| CY1108217T1 (el) | Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης | |
| EA200400881A1 (ru) | Азаарилпиперазины | |
| DE60128540D1 (de) | Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen | |
| EP1086099A4 (de) | Sulfonsäure- oder sulfonylamino-n-(heteroaralkyl)-azaheterozyklylamidverbindungen | |
| CA2274686A1 (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| IS2630B (is) | Meðferð á fráhvarfseinkennum | |
| ATE414522T1 (de) | Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure | |
| DE60214527D1 (de) | Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit | |
| PL1656131T3 (pl) | Zastosowanie betainy w leczeniu chromania przestankowego | |
| ATE395060T1 (de) | Verwendung von tenatoprazol zur behandlung von gastroösophogalem reflux | |
| Raghuraman et al. | Enhanced neuropeptide Y synthesis during intermittent hypoxia in the rat adrenal medulla: role of reactive oxygen species–dependent alterations in precursor peptide processing | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| SE9902597D0 (sv) | New use | |
| DE60323613D1 (de) | Verwendung von tyrosinkinase-hemmern zur behandlung von erkrankungen im zusammenhang mit substanzgebrauch | |
| EA200600284A1 (ru) | Дооперационное лечение послеоперационной боли | |
| DK1675611T3 (da) | Terapeutiske anvendelser for C-peptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1553943 Country of ref document: EP |